期刊文献+

氧化异阿朴菲-褪黑素杂合体的合成、抗β淀粉样蛋白聚集及抗氧化活性 被引量:2

Synthesis,Inhibition of β-Amyloid Aggregation and Antioxidation of Oxoisoaporphine-Melatonin Hybrids
下载PDF
导出
摘要 基于多靶向策略设计合成了氧化异阿朴菲-褪黑素杂合化合物,测试了它们的抗胆碱酯酶性能及相应的抑制动力学、抗氧化能力和抑制乙酰胆碱酯酶诱导的β-淀粉样蛋白(Aβ)聚集能力。实验结果表明,所合成的化合物对乙酰胆碱酯酶具有中等强度抑制力,其抑制IC50值在微摩尔浓度水平,属于非竞争性抑制剂;对乙酰胆碱酯酶诱导的Aβ淀粉样蛋白聚集的抑制率达到79.3%~84.7%;抗氧化能力是trolox的1.1~1.5倍。 Two oxoisoaporphine-melatonin hybrids(compound 2a and 2b) have been designed,synthesized and tested for their ability to inhibit acetylcholinesterase,butyrylcholinesterase,acetylcholinesterase-induced β-amyloid(Aβ) aggregation.Their inhibitory mechanism and antioxidant properties were also studied.The synthetic compounds(2a and 2b) exhibited moderate AChE inhibitory activity with IC50 values in the micromolar range in most cases.Non-competitive binding mode was found for these derivatives.Moreover,the compounds(2a and 2b) exhibit high acetylcholinesterase-induced Aβ antiaggregating activity with inhibitory potencies ranging from 79.3% to 84.7%,and significant antioxidant properties with peroxyl radical absorbance capacities ranging from 1.1-to 1.5-fold the value of trolox.
出处 《应用化学》 CAS CSCD 北大核心 2012年第5期510-514,共5页 Chinese Journal of Applied Chemistry
基金 广西自然科学基金资助项目(083095) 广西研究生教育创新计划项目(2010106020703M68)
关键词 氧化异阿朴菲衍生物 褪黑素 胆碱酯酶 抗氧化 抗Aβ聚集 oxoisoaporphine derivatives melatonin cholinesterase antioxidant Aβ antiaggregating
  • 相关文献

参考文献13

  • 1Hardy J, Selkoe D J. The Amyloid Hypothesis of Alzheimer's Disease:Progress and Problems on the Road to Therapeutics [ J]. Science,2002,297(5580) :353-356.
  • 2Castro A,Martinez A.Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors[J].Curr Pharm Des,2006,12(33):4377-4387.
  • 3Bolognesi M L, Cavalli A,Melchiorre C. Memoquin:A Multi-target-directed Ligand as an innovative Therapeutic Opportunity for Alzheimer's Disease[ J]. Neurotherapeutics,2009 ~6( 1 ) : 152-162.
  • 4De Ferrari G V,Canales M A,Shin I,et al.A Structural Motif of Acetylcholinesterase that Promotes Amyloid Beta-PeptideFibril Formation[J].Biochemistry,2001,40(35):10447-10457.
  • 5Camps P,Formosa X,Galdeano C,et al.Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcho-linesterase-and beta-Amyloid-Directed Anti-Alzheimer Compounds[J].J Med Chem,2009,52(17):5365-5379.
  • 6Tang H,Ning F X,Wei Y B,et al.Derivatives of Oxoisoaporphine Alkaloids:A Novel Class of Selective AcetylcholinesteraseInhibitors[J].Bioorg Med Chem Lett,2007,17(13):3765-3768.
  • 7Tang H,Ning F X,Wei Y B ,et al. Derivatives of Oxoisoaporphine Alkaloids:A Novel Class of Selective Acetylcholinesterase Inhibitors [ J ]. Bioorg Med Chem Lett,2007,17 ( 13 ) : 3765-3768.
  • 8Tang H,Wei Y B,Zhang C,et al.Synthesis,Biological Evaluation and Molecular Modeling of Oxoisoaporphine andOxoaporphine Derivatives as New Dual Inhibitors of Acetylcholinesterase/butyrylcholinesterase[J].Eur J Med Chem,2009,44(6):2523-2532.
  • 9Rodriguez-Franco M I,Fernandez-Bachiller M I,Perez C,et al.Novel Tacrine-Melatonin Hybrids as Dual-Acting Drugs forAlzheimer Disease,with Improved Acetylcholinesterase Inhibitory and Antioxidant Properties[J].J Med Chem,2006,49(2):459-462.
  • 10Ellman G L,Courtney K D,Andres V,et al.A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity[J].Biochem Pharmacol,1961,7:88-95.

同被引文献32

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部